Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.45
Delayed Data
As of 1:21pm ET
 +0.021 / +0.86%
Today’s Change
2.00
Today|||52-Week Range
5.18
+2.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-35.3M-148.3M-169.6M-77.1M
 
 
 
 
 
Depreciation33.0M94.7M86.2M73.3M
 
 
 
 
 
Total Other Cash Flow12.5M36.4M44.3M1.6M
 
 
 
 
 
Funds From Operations-1.6M-10.5M-39.2M-2.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-10.5M4.2M-22.7M3.5M
 
 
 
 
 
Net Cash Flow - Operating Activities8.9M-14.7M-16.5M-5.9M
 
 
 
 
 
 
InvestingCapital Expenditures-1.2M-1.2M-984.0K-18.0K
 
 
 
 
 
Fixed Asset Disposal1.4M0.00--2.0M
 
 
 
Net Assets From Acquisitions -255.0M-88.0M-583.0K0.00
 
 
 
 
Other Investing - Sources4.9M4.9M0.000.00
 
 
 
Net Cash Flow Investing-249.9M-84.3M-1.6M2.0M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings270.9M132.3M0.0016.6M
 
 
 
 
Long Term Debt Reduction-9.6M-10.1M-21.5M-18.1M
 
 
 
 
 
Net Proceeds Stock Sale2.1M395.0K19.8M2.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing404.0K0.00----
 
 
Other Uses - Financing3.6M2.3M23.0K112.0K
 
 
 
 
 
Net Cash Flow - Financing260.2M120.4M-1.7M402.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash19.2M21.3M-19.8M-3.6M